TOPIC
Nasdaq
3 stories covering nasdaq — fund closes, LP allocations, regulatory filings, deal flow, and fundraising signals from PipelineRoad's editorial team.
Oura puts Nasdaq IPO on hold amid IPO market uncertainty
Oura has paused its planned Nasdaq IPO, citing uncertainty in the IPO market, after outlining a 50 million share offering at $40 to $44 per share.
Electra Therapeutics raises $350M in upsized Nasdaq IPO for SIRP-targeting drugs
Electra Therapeutics priced an upsized IPO at $15 per share, raising $350 million and debuting on Nasdaq as ETRA to fund clinical research in precision immunology.
Cerebras Shares Close Up 68% at $311.07 in Nasdaq Debut
Cerebras Systems begins trading on Nasdaq under ticker CBRS after pricing its IPO at $185 per share.
Daily capital raising signals
Get fund close, LP allocation, and deal flow news before it hits the mainstream.
